上海谊众上半年归属净利润3800.38万元，同比增长10.13%

Core Insights - Shanghai Yizhong (688091) reported a revenue of 160 million yuan for the first half of 2025, representing a year-on-year growth of 31.48% [1] - The net profit attributable to shareholders reached 38.0038 million yuan, showing a year-on-year increase of 10.13% [1] - The significant revenue growth is primarily attributed to the inclusion of the core product, paclitaxel micelles, in the national medical insurance catalog, leading to a remarkable sales increase of 487% compared to the same period last year [1]